Quick Answer
PMV Pharmaceuticals, Inc. reported Total Assets of $116.56 million for fiscal year 2025.
PMV Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $116.56M | -39.1% |
| 2024 | $191.29M | -24.1% |
| 2023 | $252.15M | -6.7% |
| 2022 | $270.31M | -18.5% |
| 2021 | $331.57M | -9.3% |
| 2020 | $365.53M | +254.8% |
| 2019 | $103.03M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $133.84M | -40.1% | -12.4% |
| June 30, 2025 | $152.85M | -35.7% | -10.4% |
| March 31, 2025 | $170.61M | -28.0% | -10.8% |
| December 31, 2024 | $191.29M | -24.1% | -14.4% |
| September 30, 2024 | $223.50M | -14.4% | -5.9% |
| June 30, 2024 | $237.54M | -1.9% | +0.3% |
| March 31, 2024 | $236.88M | -6.7% | -6.1% |
| December 31, 2023 | $252.15M | -6.7% | -3.4% |
- PMV Pharmaceuticals, Inc. showed a decrease of -39.1% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, PMV Pharmaceuticals, Inc.’s total assets has grown by 13.1% (from $103.03 million to $116.56 million).
- The most recent figure is from PMV Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: